SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
China’s First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent’s TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
December 25, 2025
 · 
11 min read
Press Releases
Modalis Announces Publication in Human Gene Therapy of Study Demonstrating Efficient LAMA1 Gene Activation for the Treatment of LAMA2-CMD
December 25, 2025
 · 
3 min read
Press Releases
Caliway’s Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies
December 25, 2025
 · 
6 min read
Press Releases
FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
December 25, 2025
 · 
17 min read
Press Releases
PharmaEssentia USA Announces Appointment of Jeffrey Williams as Independent Director
December 25, 2025
 · 
2 min read
Press Releases
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
December 25, 2025
 · 
8 min read
Press Releases
Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study
December 25, 2025
 · 
4 min read
Press Releases
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
December 25, 2025
 · 
5 min read
Press Releases
Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy
December 25, 2025
 · 
11 min read
Press Releases
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 25, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
December 25, 2025
 · 
5 min read
Press Releases
Italfarmaco and JCR Pharmaceuticals Announce Commercialisation Agreement for Givinostat in Japan and Strategic Collaboration in Rare Disease
December 25, 2025
 · 
8 min read
Press Releases
Alvotech’s Financial Calendar for 2026
December 25, 2025
 · 
1 min read
Press Releases
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
December 24, 2025
 · 
13 min read
Press Releases
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
December 24, 2025
 · 
11 min read
Press Releases
WuXi Biologics Recognized by Hong Kong ESG Reporting Awards 2025 for Outstanding ESG Disclosure
December 24, 2025
 · 
3 min read
Press Releases
Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
December 24, 2025
 · 
3 min read
Press Releases
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
December 24, 2025
 · 
15 min read
Press Releases
Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study
December 24, 2025
 · 
5 min read
Press Releases
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug ‘SNB-101' on Gastric Cancer.
December 24, 2025
 · 
3 min read
Press Releases
LSL PHARMA GROUP ANNOUNCES CLOSING OF THE ACQUISITION OF JUNO OTC AND FINAL $2M CLOSING OF UPSIZED $12M OFFERING
December 24, 2025
 · 
6 min read
Press Releases
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
December 24, 2025
 · 
4 min read
Press Releases
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
December 24, 2025
 · 
11 min read
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
December 24, 2025
 · 
12 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2025
December 15, 2025
 · 
3 min read
Press Releases
InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial
December 15, 2025
 · 
4 min read
Press Releases
Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
December 15, 2025
 · 
3 min read
Press Releases
Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
December 15, 2025
 · 
1 min read
Press Releases
NervGen Pharma Announces Proposed Amendment to Warrants
December 12, 2025
 · 
5 min read
Press Releases
InMed Provides Update on BayMedica Commercial Business
December 12, 2025
 · 
5 min read
Press Releases
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
December 12, 2025
 · 
6 min read
Press Releases
Non-Opioid ‘Pain Sponge’ Therapy Halts Cartilage Degeneration and Relives Chronic Pian
The announcement was made at the International Society of Stem Cell Research (ISSCR) Symposium Accelerating PSC-Derived Cell Therapies: Starting with the End in Mind
December 12, 2025
 · 
1 min read
Press Releases
Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study, STARt-002, at the 2025 San Antonio Breast Cancer Symposium
December 12, 2025
 · 
5 min read
Press Releases
Novartis breaks ground on flagship manufacturing hub in North Carolina
December 12, 2025
 · 
7 min read
Load More